Antonio Jirillo

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

Adriano Paccagnella, Antonio Orlando, C. Marchiori et al. · JNCI Journal of the National Cancer Institute · 1994 · 420 citations

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

P. L. Zorat, A. Paccagnella, G Cavaniglia et al. · JNCI Journal of the National Cancer Institute · 2004 · 186 citations · Full text

M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis

Elisabetta Rossi, Umberto Basso, Romina Celadin et al. · Clinical Cancer Research · 2010 · 128 citations · Full text

Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer

Elisabetta Rossi, Matteo Fassan, Michele Aieta et al. · British Journal of Cancer · 2012 · 60 citations · Full text